Another recent report found that myosin-9 (MYH9) acts as an lncRNA-binding protein that targets the FOXE1 promoter region through interaction with PTCSC2 and exerts its regulatory function in thyroid cancer via downstream pathways; this may be the molecular mechanism by which the gene and rs965513 act (33). Here, PTCSC2 is linked to thyroid gland carcinoma.